Compounds of formula (I)
are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions of compounds of formula (I), methods for using such compounds and compositions, and a process for preparing the compounds.
式(I)的化合物可用于治疗由
组胺-3受体
配体预防或改善的疾病或疾病。还披露了化合物的制药组合物(I)、使用这种化合物和组合物的方法以及制备这种化合物的过程。